Teacher Retirement System Of Texas Rigel Pharmaceuticals Inc Transaction History

Teacher Retirement System Of Texas

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	BUY	$1.1 - $12.2 $32,018 - $355,117	29,108 Added 106.86%	56,347 $66,000
Q2 2022 Aug 09, 2022	SELL	$0.67 - $3.19 $5,219 - $24,850	-7,790 Reduced 22.24%	27,239 $31,000
Q1 2022 May 09, 2022	BUY	$2.22 - $3.45 $4,590 - $7,134	2,068 Added 6.27%	35,029 $105,000
Q4 2021 Feb 10, 2022	BUY	$2.36 - $3.57 $13,454 - $20,352	5,701 Added 20.91%	32,961 $87,000
Q3 2021 Nov 09, 2021	BUY	$3.5 - $4.5 $17,171 - $22,077	4,906 Added 21.95%	27,260 $99,000
Q2 2021 Aug 05, 2021	BUY	$3.09 - $4.54 $10,227 - $15,027	3,310 Added 17.38%	22,354 $97,000
Q1 2021 May 11, 2021	BUY	$3.35 - $4.93 $11,952 - $17,590	3,568 Added 23.06%	19,044 $65,000
Q4 2020 Feb 11, 2021	BUY	$2.35 - $3.74 $36,368 - $57,880	15,476 New	15,476 $54,000
Q4 2018 Mar 04, 2019	SELL	$2.08 - $3.36 $37,937 - $61,283	-18,239 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$2.6 - $3.59 $33,839 - $46,723	-13,015 Reduced 41.64%	18,239 $59,000
Q2 2018 Aug 06, 2018	BUY	$2.83 - $4.11 $1,092 - $1,586	386 Added 1.25%	31,254 $88,000
Q1 2018 May 08, 2018	SELL	$3.54 - $4.54 $55,974 - $71,786	-15,812 Reduced 33.87%	30,868 $109,000
Q4 2017 Feb 06, 2018	BUY	$3.23 - $4.3 $150,776 - $200,724	46,680	46,680 $181,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Teacher Retirement System Of Texas with notifications on news.